Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates-Reference-Cited by-同舟云学术

Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates

Published:2019-03-01 Issue:7 Volume:47 Page:3306-3320
ISSN:0305-1048
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Janas Maja M¹,Zlatev Ivan¹,Liu Ju¹,Jiang Yongfeng¹,Barros Scott A¹,Sutherland Jessica E¹,Davis Wendell P¹,Liu Jingxuan¹,Brown Christopher R¹,Liu Xiumin¹,Schlegel Mark K¹,Blair Lauren¹,Zhang Xuemei¹,Das Biplab¹,Tran Chris¹,Aluri Krishna¹,Li Jing¹,Agarwal Saket¹,Indrakanti Ramesh¹,Charisse Klaus¹,Nair Jayaprakash¹,Matsuda Shigeo¹,Rajeev Kallanthottathil G¹,Zimmermann Tracy¹,Sepp-Lorenzino Laura¹,Xu Yuanxin¹,Akinc Akin¹,Fitzgerald Kevin¹,Vaishnaw Akshay K¹,Smith Peter F¹,Manoharan Muthiah¹,Jadhav Vasant¹,Wu Jing-Tao¹,Maier Martin A¹

Affiliation:

1. Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142, USA

Funder

Alnylam Pharmaceuticals

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/47/7/3306/28467977/gkz140.pdf

Reference37 articles.

1. Knocking down disease: a progress report on siRNA therapeutics;Wittrup;Nat. Rev. Genet.,2015